The challenge of drug affordability in multiple myeloma around the world
A multiple myeloma patient story - a discussion between Vivien de Gunzburg and Paul Richardson
Can biosimilars ensure access to drugs for everyone?
The iwCLL 2017 meeting
Novel agents in multiple myeloma: considering toxicity and side effects